Emerging parasitic infections

Clinics in Laboratory Medicine

Volumn 24, Issue 3, 2004, Pages 737-772

  Christie, John D ^a   Garcia, Lynne S ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b LSG and Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

BABESIA; BABESIOSIS; CANADA; CLINICAL FEATURE; CRYPTOSPORIDIOSIS; CYSTICERCOSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; ENTEROBIUS VERMICULARIS; EPIDEMIC; GIARDIASIS; HOST; HOST PARASITE INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE SYSTEM; LABORATORY TEST; LEISHMANIASIS; LIFE CYCLE; MALARIA; MICROSPORIDIOSIS; NEUROCYSTICERCOSIS; PARAGONIMUS; PARASITE; PARASITE SURVIVAL; PARASITE TRANSMISSION; PARASITOSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; SYMPTOM; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; TRYPANOSOMA; TRYPANOSOMIASIS; UNITED STATES; VASCULARIZATION; WESTERN EUROPE; WORLD HEALTH ORGANIZATION;

COMMUNICABLE DISEASES, EMERGING; HUMANS; INCIDENCE; PARASITIC DISEASES;

EID: 8444236622     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2004.05.010     Document Type: Review

References (69)

1. Krieger J.N. Trichomoniasis in men: old issues and new data. Sex Transm Dis. 22:1995;83-96
2. Kingston M.A., Bansal D., Carlin E.M. "Shelf life" of Trichomonas vaginalis. Inter J STD AIDS. 14:2003;28-29
3. Hobbs M.M., Kazembe P., Reed A.W., Miller W.C., Nkata E., Zimba D., et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis. 26:1999;381-387
4. Garcia L.S. Diagnostic medical parasitology. 4th edition :2001;ASM Press, Washington (DC)
5. Remington J.S., Thulliez P., Montoya J.C. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol. 42:2004;941-945
6. Jones JL, Kruszon-Moran D, Wilson M. Toxoplasma gondii infection in the United States, 1999-2000. Emerg Infect Dis [serial online] 2003. Available at:http://www.cdc.gov/ncidod/EID/vol9no11/03-0098.htm. Accessed April 10, 2004.
7. Garcia L.S. Laboratory identification of the microsporidia. J Clin Microbiol. 40:2002;1892-1901
8. Orenstein J.M. Diagnostic pathology of microsporidiosis. Ultrastruct Pathol. 27:2003;141-149
9. Hunter P.R., Nichols G. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev. 15:2002;145-154
10. Chappell C.L., Okhuysen P.C. Cryptosporidiosis. Curr Opin Infect Dis. 15:2002;523-527
11. Clark D.P. New insights into human cryptosporidiosis. Clin Microbiol Rev. 12:1999;554-563
12. Gavin P.J., Kazacos K.R., Tan T.Q., Brinkman W.B., Byrd S.E., Davis A.T., et al. Neural larva migrans caused by the raccoon roundworm Baylisascaris procyonis. Pediatr Infect Dis J. 21:2002;971-975
13. Gavin P.J., Shulman S.T. Raccoon roundworm (Baylisascaris procyonis). Pediatr Infect Dis J. 22:2003;651-652
14. Cummingham C.K., Kazacos K.R., McMillan J.A., Lucas J.A., McAuley J.E., Wozniak E.J., et al. Diagnosis and management of Baylisascaris procyonis infection in an infant with nonfatal meningoencephalitis. Clin Infect Dis. 18:1994;868-872
15. Eberhard M.L., Nase E.K., Won K.Y., Punkosdy G.A., Bishop H.S., Johnston S.P. Baylisascaris procyonis in the metropolitan Atlanta area. Emerg Infect Dis. 9:2003;1636-1637
16. Castilla E.A., Jessen R., Sheck D.N., Procop G.W. Cavitary mass lesion and recurrent pneumothoraces due to Paragonimus kellicotti infection: North American paragonimiasis. Am J Surg Pathol. 27:2003;1157-1160
17. DeFrain M., Hooker R. North American paragonimiasis: case report of a severe clinical infection. Chest. 121:2002;1368-1372
18. Mariano E.G., Borja S.R., Vruno M.J. A human infection with Paragonimus kellicotti (lung fluke) in the United States. Am J Clin Pathol. 86:1986;685-687
19. Procop G.W., Marty A.M., Sheck D.N., Mease D.R., Maw G.M. North American paragonimiasis. A case report. Acta Cytol. 44:2000;75-80
20. Yee B., Hsu J.I., Favour C.B., Lohne E. Pulmonary paragonimiasis in Southeast Asians living in the central San Joaquin Valley. West J Med. 156:1992;423-425
21. Warrell D.A., Gilles H.M. Essential malariology. 4th edition :2002;Hodder Headline Group, London
22. Milne L., Chiodini P.L., Warhurst D.C. Accuracy of routine laboratory diagnosis of malaria in the United Kingdom. J Clin Pathol. 47:2002;740-742
23. McKenzie F.E., Sirichaisinthop J., Miller R.S., Gasser R.A. Jr., Wongsrichanalai C. Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am J Trop Med Hyg. 69:2003;372-376
24. Bell D. Malaria rapid diagnostic tests: one size may not fit all. [letter] Clin Microbiol Rev. 15:2002;771
25. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev. 15:2002;66-78
26. Moody A. Malaria rapid diagnostic tests: one size may not fit all. [reply to letter] Clin Microbiol Rev. 15:2002;771-772
27. Singh B., Sung L.K., Matusop A., Radhakrishnan A., Shamsul S.S.G., Cox-Singh J., et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet. 353:2004;1017-1024
28. Phillips R.S. Current status of malaria and potential for control. Clin Microbiol Rev. 14:2001;208-226
29. Remme J.H.F., Binka F., Nabarro D. Toward a framework and indicators for monitoring roll back malaria. Am J Trop Med Hyg. 64:(1-2):2001;S76-S84
30. Molyneux D.H. Vector-borne parasitic diseases - an overview of recent changes. Inter J Parasitol. 28:1998;927-934
31. Trape J.-F. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 64:(1-2):2001;S12-S17
32. Hoetz P.J., Remme J.H.F., Buss P., Aleyne G., Morel C., Breman J.G. Combating tropical infectious diseases: report of the Disease Control Priorities in Developing Countries Project. Clin Infect Dis. 38:2004;871-878
33. Centers for Disease Control and Prevention. Surveillance summaries, July 18, 2003. MMWR Morb Mtl Wkly Rep. 52:(No. SS-5):2003;1-4
34. Shiff C. Integrated approach to malaria control. Clin Microbiol Rev. 15:2002;278-293
35. Centers for Disease Control and Prevention. Local transmission of Plasmodium vivax malaria - Palm Beach County, Florida, 2003. MMWR Morb Mtl Wkly Rep. 52:2003;908-911
36. Barrett M.P., Burchmore R.J.S., Stich A., Lazzari J.O., Frash A.C., Cazzulo J.J., et al. The trypanosomiasis. Lancet. 362:2003;1469-1480
37. Lejon V., Boelaert M., Jannin J., Moore A., Buscher P. The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa. Lancet Infect Dis. 3:2003;804-808
38. Welburn S.C., Odiit M. Recent developments in human African trypanosomiasis. Curr Opin Infect Dis. 15:2002;477-484
39. Hutchinson O.C., Fevre E.M., Carrington M., Welburn S.C. Lessons learned from the emergence of a new Trypanosoma brucei rhodesiense sleeping sickness focus in Uganda. Lancet Infect Dis. 3:2003;42-45
40. Telford S.R. III, Maguire J.H. Babesiosis. Guerrant R.L., Walker D.H., Weller P.F. Tropical infectious diseases: principles, pathogens, and practice. 1999;767-773 Churchill Livingstone, Philadelphia
41. Homer M.J., Aguilar-Delfin I., Telford S.R. III, Krause P.J., Persing D.H. Babesiosis. Clin Microbiol Rev. 13:2000;451-469
42. Krause P.J., McKay K., Gadbaw J., Christianson D., Closter L., Telford S.R. III, et al. Increasing health burden of human babesiosis in endemic sites. Am J Trop Med Hyg. 68:2003;431-436
43. Eskow E.S., Krause P.J., Spielman A., Freeman K., Aslanzadeh J. Southern extension of the range of human babesiosis in the eastern United States. J Clin Microbiol. 37:1999;2051-2052
44. Herwaldt B.L., McGovern P.C., Gerwel M.P., Easton R.M., MacGregor R.R. Endemic babesiosis in another eastern state: New Jersey. Emerg Infect Dis. 9:2003;184-188
45. Herwaldt B.L., de Bruyn G., Pieniazek N.J., Homer M., Lofy K.H., Slemenda S.B., et al. Babesia divergens-like infection, Washington State. Emerg Infect Dis. 10:2004;622-629
46. Krause P.J., Spielman A., Telford S.R. III, Sikand V.K., McKay K., Christianson D., et al. Persistent parasitemia after acute babesiosis. N Engl J Med. 339:1998;160-165
47. Herwaldt B.L., Neitzel D.F., Gorlin J.B., Jensen K.A., Perry E.H., Peglow W.R., et al. Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period. Transfusion. 42:2002;1154-1158
48. Pantanowitz L., Telford S.R. III, Cannon M.E. The impact of babesiosis on transfusion medicine. Transfus Med Rev. 16:2002;131-143
49. Leiby D.A. Babesia and other parasites. Brecher M.E. Bacterial and parasitic contamination of blood components. 2003;179-200 AABB Press, Bethesda (MD)
50. Tyler K.M., Engman D.M. The life cycle of Trypanosoma cruzi revisited. Inter J Parasitol. 31:2001;472-481
51. Guitierrez Y. Diagnostic pathology of parasitic infections with clinical correlations. 2nd edition :2000;Oxford University Press, New York
52. Gurtler RE, Segura EL, Cohen JE. Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis [serial online] 2003; Available at: http://www.cdc.gov/ncidod/EID/vol9no1/02-0274.htm. Accessed April 14, 2003.
53. Collazos J. Opportunistic infections of the CNS in patients with AIDS: diagnosis and management. CNS Drugs. 17:2003;869-887
54. Leiby D.A., Herron R.M. Jr., Read E.J., Lenes B.A., Stumpf R.J. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion. 42:2002;549-555
55. Shulman I.A. Transmission of T cruzi by blood transfusion. Brecher M.E. Bacterial and parasitic contamination of blood components. 2003;157-178 AABB Press, Bethesda (MD)
56. Fernandez-Guerrero M.L., Robles P., Rivas P., Mojer F., Muniz G., de Gorgolas M. Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Trop. 90:2004;11-16
57. Schallig H.D., Canto-Cavalheiro M., da Silva E.S. Evaluation of the direct agglutination test and the rK39 dipstick test for the sero-diagnosis of visceral leishmaniasis. Mem Inst Oswaldo Cruz. 97:2002;1015-1018
58. Veeken H., Ritmeijer K., Seaman J., Davidson R. Comparison of an rK39 dipstick rapid test with direct agglutination test and splenic aspiration for the diagnosis of kala-azar in Sudan. Trop Med Int Health. 8:2003;164-167
59. Centers for Disease Control and Prevention. Update: cutaneous leishmaniasis in US military personnel - southwest/central Asia, 2002-2004. MMWR Morb Mtl Wkly Rep. 53:2004;264-265
60. Centers for Disease Control and Prevention. Two cases of visceral leishmaniasis in US military personnel - Afghanistan, 2002-2004. MMWR Morb Mtl Wkly Rep. 53:2004;265-268
61. Garcia H.H., Del Brutto O.H. Taenia solium cysticercosis. Infect Dis Clin North Am. 14:2000;97-119
62. Garcia H.H., Gonzalez A.E., Evans C.A.W., Gilman R.H., for the Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet. 362:2003;547-556
63. Rosenfeld E. Neurocysticercosis update. Pediatr Infect Dis J. 22:2003;181-182
64. Del Brutto O.H., Rajshekhar V., White A.C. Jr., Tsang V.C., Nash T.E., Takayanagui O.M., et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 57:2001;177-183
65. Henneman P.L., DeRoos F., Lewis R.J. Determining the need for admission in patients with new onset seizures. Ann Emerg Med. 24:1994;1108-1114
66. Ong S., Talan D.A., Moran G.J., Mower W., Newdow M., Tsang V.C., et al. Neurocysticercosis in radiographically imaged seizure patients in US emergency departments. Emerg Infect Dis. 8:2002;608-613
67. Townes J.M., Hoffmann C.J., Kohn M.A. Neurocysticercosis in Oregon, 1995-2000. Emerg Infect Dis. 10:2004;508-510
68. Mitchell W.G., Crawford T.O. Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. Pediatrics. 82:1988;76-82
69. Rosenfield E.A., Byrd S.E., Shulman S.T. Neurocysticercosis among children in Chicago. Clin Infect Dis. 23:1996;262-268